Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Contract Win

20 Sep 2006 07:00

e2v technologies PLC20 September 2006 20 September 2006 e2v technologies PLC e2v secures contract win worth £6.2M e2v technologies, a specialist developer and manufacturer of high technology components and sub-systems, announces a key UK Ministry of Defence (MOD) multi-year contract win worth a total of £6.2M. The £6.2M UK MOD contract is for the development and evaluation of a new high power, high bandwidth microwave transmitter from the company's Electronic Tubebusiness. e2v will be the prime contractor for the project in a consortium,which includes the University of Strathclyde and TMD Technologies Ltd. Deliveries against the contract will be completed over a three-year period. Keith Attwood, Chief Executive of e2v said: "The award of this contract is the result of many years' work between e2v andthe UK MOD, and illustrates our continued growth and expertise in deliveringdefence solutions." For further information: e2v technologies plc Tel: 01245 493493Keith Attwood/Mike Hannantwww.e2v.com Gavin Anderson & Company Tel: 020 7554 1400Keith Brookbank/Fergus Wylie NOTES FOR EDITORSe2v technologies plce2v technologies delivers the radio frequency and sensing technology that enables some of the world's most innovative medical and science, aerospace and defence, and industrial and commercial systems. For the year ended 31 March2006, e2v achieved sales of £112.3m. It is listed on the London Stock Exchange(e2v.l). In July 2006 the e2v group increased its size through acquisition of a facilityin Grenoble France, effectively increasing the group's annual turnover to circa£180m. e2v is a leading developer and manufacturer of high-technology electronic components and subsystems, which it supplies into three core areas: *Medical & Science: Sensor technology includes imaging sensors for intra-oral and panoramic dental X-ray, mammography, life science applications and X-raymicroscopy. Electronic tubes are the enabling technology behind radiotherapy cancer treatments, microwave medical therapy and high-energy physics. *Aerospace & Defence: Sensor technology includes military surveillance, targeting and guidance, space-based imaging and astronomy and radar & electronicwarfare and roadband data converters and microprocessors for aerospace applications. Electronic tubes provide the enabling technology behind radars,electronic countermeasures (ECM), electronic warfare and satellite communications. *Commercial & Industrial: Sensor technology includes marine radars, industrialsafety sensors, automotive radars and alarms and thermal imaging cameras used by fire fighters, CCD and CMOS highresolution area scan cameras for industrial inspection. Electronic tubes provideenabling technology behind TV broadcast, satellite communications, marine radar and food & industrial processing. In 2006 e2v won a Queen's award for Enterprise, granted in the Innovation category, for its L3Vision(tm) imaging sensors and cameras used in aerospace, medical and scientific imaging systems. e2v has approximately 1,800 employees worldwide with 3 UK based manufacturing sites in Chelmsford, Lincoln and High Wycombe, and a facility in Grenoble, France. In addition e2v has sales offices in the UK, USA, Germany and France, as well as a network of distributors covering other key territories. Further information on e2v technologies plc is available from its website,www.e2v.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Jan 20144:37 pmRNSHolding(s) in Company
5th Dec 201311:42 amRNSAdditional Listing
27th Nov 201311:35 amRNSGeneral Meeting
19th Nov 20134:25 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
14th Nov 20133:27 pmRNSNotification of Major Interest in Shares
14th Nov 201312:49 pmRNSNotice of General Meeting
6th Nov 20134:57 pmRNSTransaction in Own Shares
4th Nov 201311:44 amRNSDirector/PDMR Shareholding
4th Nov 20137:00 amRNSHalf-year results for six months to 30 Sept 2013
18th Oct 20137:00 amRNSAppointment of Chief Executive
15th Oct 20137:00 amRNSPeriod end update
14th Oct 20134:15 pmRNSHolding(s) in Company
1st Oct 20134:51 pmRNSTransaction in Own Shares
27th Sep 20134:18 pmRNSPurchase of Own Shares
23rd Sep 20134:00 pmRNSShare buy-back programme
19th Aug 20132:15 pmRNSTotal Voting Rights
13th Aug 20134:15 pmRNSHolding(s) in Company
13th Aug 20131:30 pmRNSDirector/PDMR Shareholding
23rd Jul 20137:00 amRNSDirector/PDMR Shareholding
19th Jul 20137:00 amRNSAwards under Long Term Incentive Plan
17th Jul 20131:45 pmRNSAnnual General Meeting 2013
17th Jul 20137:00 amRNSDirectorate Change
17th Jul 20137:00 amRNSInterim Management Statement
1st Jul 20134:35 pmRNSHolding(s) in Company
26th Jun 20134:29 pmRNSHolding(s) in Company
26th Jun 201311:11 amRNSHolding(s) in Company
12th Jun 201312:00 pmRNSDirectorate Change
20th May 20132:20 pmRNSDirector/PDMR Shareholding
20th May 20137:00 amRNSResults for the year ended 31 March 2013
25th Apr 20133:58 pmRNSNotification of Major Interest in Shares
22nd Apr 20135:00 pmRNSNotification of Major Interest in Shares
16th Apr 20137:00 amRNSTrading Statement
9th Apr 201310:00 amRNSTotal Voting Rights
18th Mar 20134:00 pmRNSNotification of Major Interest in Shares
18th Mar 20137:00 amRNSe2v wins ?10m ESA space science contract
6th Mar 20133:11 pmRNSHolding(s) in Company
6th Mar 20132:15 pmRNSHolding(s) in Company
5th Mar 20137:00 amRNSContract Renewal
22nd Feb 20132:02 pmRNSNotification of Major Interest in Shares
14th Feb 201311:00 amRNSDirector/PDMR Shareholding
12th Feb 20134:43 pmRNSDirector/PDMR Shareholding
12th Feb 201311:10 amRNSHolding(s) in Company
11th Feb 20134:13 pmRNSTotal Voting Rights
11th Feb 20137:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20137:00 amRNSInterim Management Statement
8th Jan 201311:40 amRNSTotal Voting Rights
7th Jan 20131:59 pmRNSDirector/PDMR Shareholding
7th Dec 20127:00 amRNSContract Renewal
3rd Dec 20127:00 amRNSSale of land
30th Nov 20123:39 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.